Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy | HKMJ
Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM
The effect of urethral catheterization on the level of prostate-specific antigen Izadpanahi MH, Salimi H, Javid A, Eslami S - J Res Med Sci
Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
ESTRO - Session Item
Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
I'm officially 4-years NED, undetectable PSA! - Gogs Gagnon
Serum PSA levels by fasting time after adjustment for the effect of age | Download Table
Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity | PLOS ONE
Usefulness of ultra‑sensitive prostate‑specific antigen following radical prostatectomy
Biotinylated Anti-PSA (Prostate Specific Antigen) Rabbit Monoclonal Antibody, Clone RM323 – RevMAb
Integrated formulas to forecast prostate cancer: the parameters of influencing the prostate specific antigen level as an adjunct to prostate specific antigen and multi-parametric MRI to predict prostate cancer before biopsy -
Kaplan-Meier survival curves of (a) PSA-progression-fre | Open-i
I'm officially 4-years NED, undetectable PSA! - Gogs Gagnon
Age, prostate volume, and PSA results of 212 patients diagnosed with... | Download Table
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -
Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA | Clinical Proteomics | Full Text
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE
KoreaMed Synapse
Early prostate-specific antigen (PSA) response or progression and survival | Download Table
